Antagonism of morphine-induced antinociception by tetrandrine is dependent on serotonergic mechanisms

被引:16
|
作者
Zhang, YH
Fang, LH
机构
[1] Chungbuk Natl Univ, Coll Med, Dept Pharmacol, Kaeshin Dong 361763, Cheongju, South Korea
[2] Beijing Univ, Dept Pharmacol, Sch Basic Med, Beijing 100083, Peoples R China
关键词
antinociception; 5-HT; morphine; serotonergic; tail flick; tetrandrine;
D O I
10.1016/S0024-3205(01)01230-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
(1)Tetrandrine (TET), a non-specific calcium antagonist, inhibited morphine-induced antinociception. in the tail-flick test in mice. This study was undertaken to assess the mechanism of the antagonism of morphine-induced antinociception by TET. Morphine-induced antinociception. was prevented by pretreatment with TET in the tail-flick but not in the tail-pinch tests carried out in mice and this antagonism was abolished by pretreatment of a serotonin precursor, 5-hydroxytryptophan (5-HTP), but not by the pretreatment of a noradrenaline precursor, L-dihydroxyphenylalanine (L-DOPA), in the tail-flick test. These results indicate that serotonergic mechanisms are involved in the antagonism of morphine-induced antinociception by TET. On the other hand, the development of morphine-induced analgesic tolerance was not prevented by TET. This result, in agreement with other reports, also indicates the possible dissociation of morphine analgesic effect from its tolerance-inducing effect. In addition, TET suppressed the 5-hydroxytryptamine (5-HT)-induced head twtch response. This result provides additional evidence that TET may modulate serotonergic function and the antagonism of morphine-induced antinociception by TET is dependent on serotonergic mechanisms. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1429 / 1439
页数:11
相关论文
共 50 条
  • [41] Vigabatrin attenuates the development and expression of tolerance to morphine-induced antinociception in mice
    Chavooshi, Behzad
    Saberi, Mehdi
    Tehrani, Said Pournaghash
    Bakhtiarian, Azam
    Ahmadiani, Abolhassan
    Haghparast, Abbas
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 93 (02) : 155 - 159
  • [42] PRIOR MORPHINE EXPOSURE ENHANCES IBOGAINE ANTAGONISM OF MORPHINE-INDUCED LOCOMOTOR STIMULATION
    PEARL, SM
    JOHNSON, DW
    GLICK, SD
    PSYCHOPHARMACOLOGY, 1995, 121 (04) : 470 - 475
  • [43] Tolerance to morphine-induced antinociception is decreased by chronic sucrose or polycose intake
    D'Anci, KE
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 63 (01) : 1 - 11
  • [44] Potentiation of Morphine-Induced Antinociception by Propranolol: The Involvement of Dopamine and GABA Systems
    Afify, Elham A.
    Andijani, Najlaa M.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [45] Contribution of spinal μ1-opioid receptors to morphine-induced antinociception
    Sato, T
    Sakurada, S
    Takahashi, N
    Sakurada, T
    Tan-No, K
    Wako, K
    Kisara, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 369 (02) : 183 - 187
  • [46] Modulation of morphine-induced antinociception by palatable solutions in male and female rats
    Kanarek, RB
    Homoleski, B
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2000, 66 (03) : 653 - 659
  • [47] Involvement of GABAergic modulation of the nucleus submedius (Sm) morphine-induced antinociception
    Jia, H
    Xie, YF
    Xiao, DQ
    Tang, JS
    PAIN, 2004, 108 (1-2) : 28 - 35
  • [48] EFFECT OF MIDBRAIN AND DIENCEPHALIC LESIONS ON NOCICEPTION AND MORPHINE-INDUCED ANTINOCICEPTION IN RAT
    BEVAN, T
    PERT, A
    FEDERATION PROCEEDINGS, 1975, 34 (03) : 713 - 713
  • [49] THE ROLE OF MU-RECEPTOR SUBTYPES ON MORPHINE-INDUCED ANTINOCICEPTION IN MICE
    SAKURADA, S
    SATO, T
    TAKAHASHI, N
    KAWAMURA, S
    TANNO, K
    SAKURADA, T
    KISARA, K
    NEUROSCIENCES-JAPAN, 1995, 21 : P91 - P94
  • [50] Involvement of interleukin-31 receptor A on the morphine-induced antinociception in mice
    Arai, Iwao
    Tsuji, Minoru
    Miyagawa, Kazuya
    Miyagishi, Hiroko
    Saito, Atsumi
    Takeda, Kotaro
    Akiyama, Nohutake
    Saito, Saburo
    Takeda, Hiroshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S199 - S199